Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Cureus ; 16(7): e64655, 2024 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-39149638

RESUMO

Lemborexant is a competitive antagonist of dual orexin receptors indicated for the treatment of adult patients with insomnia characterized by difficulties with sleep onset and/or sleep maintenance that occur at least three nights per week for ≥3 months, although there is adequate opportunity for sleep. There has been no published study of its efficacy and safety in treating patients from China with insomnia. In this case report, we present four adult patients from China with insomnia who were successfully treated with add-on lemborexant or switched from benzodiazepines or Z-drugs to lemborexant. None of the four patients experienced any discomforts related to lemborexant use. In conclusion, lemborexant treatment was effective and safe in treating the four patients from China with insomnia in this case report, and more studies are warranted to further assess the efficacy and safety of lemborexant in treating patients from China with insomnia.

2.
Folia Neuropathol ; 61(3): 242-248, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37818685

RESUMO

Involving in the immune response after cerebral infarction, astrocytes could secrete large amounts of pro- and anti-inflammatory factors. The aim of this study is to investigate the effect of Wnt3a intervention on the inflammatory response of oxygen-glucose deprivation (OGD) followed by reoxygenation (OGD/R) astrocyte model, and to provide a new target for immunoprotective treatment of cerebral infarction. We constructed the OGD/R rat astrocyte model, the astrocytes were treated by different concentrations of glucose (25, 50, 100 mM) intervened with/without Wnt3a (25 µg/ml). Microscope was used to observe the cell survival in rat astrocytes. The relative expression of inflammatory factors (TNF-a, IL-6, HIF-a) in rat astrocytes was detected by qRT-PCR. The expression of inflammatory factors such as TNF-a, IL-6 and HIF-a in rat astrocytes was increased after OGD/R treatment. The Wnt3a intervention promoted cell survival and decreased the expression of inflammatory factors in rat astrocytes induced by OGD/R. There is a neuroprotective effect that Wnt3a intervention could reduce inflammatory response in the OGD/R rat astrocyte model.


Assuntos
Glucose , Oxigênio , Ratos , Animais , Glucose/metabolismo , Oxigênio/farmacologia , Oxigênio/metabolismo , Astrócitos/metabolismo , Interleucina-6/metabolismo , Interleucina-6/farmacologia , Infarto Cerebral/metabolismo
3.
Biomed Chromatogr ; 32(4)2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29178369

RESUMO

A specific, sensitive and stable high-performance liquid chromatography (HPLC)-based analytical method was established to determine the level of pefloxacin mesylate (PM) in the plasma and various tissues of chickens. Chickens were randomly assigned to 12 equal experiment groups, including 11 treatment groups and one control group. The chickens in the treatment groups received oral administration of PM and were sacrificed at different pre-determined time points, with their blood and various organs harvested, extracted and analyzed by HPLC to quantify the level of the residual antibiotic. Method validation studies indicated that the HPLC measurement showed excellent precision, reproducibility, stability and robustness. The obtained pharmacokinetic parameters suggested that PM reached peak levels in various tissues within 1-2 h after its oral administration, and was mainly concentrated in liver and kidney. The antibiotic was also found to be cleared from chicken crureus, brain, testes, ovaries and pancreas at higher rates compared with other organs. Overall, the rapid accumulation of PM could at least be partially attributed to its relatively slow organ clearance. These results could serve as a useful guidance for the rational use of PM and other quinolone-derived antimicrobials in the treatment of infectious diseases in chickens and other animals.


Assuntos
Galinhas/metabolismo , Cromatografia Líquida de Alta Pressão/métodos , Pefloxacina/análise , Pefloxacina/farmacocinética , Animais , Feminino , Modelos Lineares , Masculino , Pefloxacina/química , Reprodutibilidade dos Testes , Sensibilidade e Especificidade , Distribuição Tecidual
4.
Microb Pathog ; 112: 70-75, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-28935204

RESUMO

Robinia pseudoacacia flower, a common component in traditional Chinese medicine, has long been well-known for its high pharmaceutical value. This study aimed to assess the immunopotentiating effects of Taishan Robinia Pseudoacacia polysaccharides (TRPPS) in rabbits inoculated with a rabbit haemorrhagic disease virus (RHDV) inactivated vaccine. The rabbits were administered with the RHDV vaccine in conjunction with varying concentrations of TRPPS, and their blood samples were collected at different time points to analyze the ratio and number of blood lymphocytes. In addition, sera were prepared and analyzed to determine the overall antibody titer and the level of IL-2, a cytokine commonly used as an indicator of immune activity. The various TRPPS-supplemented vaccines were shown to be more effective in enhancing the immune functions of the inoculated rabbits compared to their polysaccharide-free counterpart, with 200 mg/mL of TRPPS exhibiting the most pronounced benefits that were comparable to those of propolis. In addition, the TRPPS-supplemented RHDV inactivated vaccines could significantly improve the survival rates of the immunized rabbits against RHDV infection. Our studies offered convincing experimental evidence for the development of TRPPS as a new type of plant-derived immunopotentiator.


Assuntos
Adjuvantes Imunológicos/farmacologia , Infecções por Caliciviridae/prevenção & controle , Medicamentos de Ervas Chinesas/farmacologia , Vírus da Doença Hemorrágica de Coelhos/imunologia , Polissacarídeos/imunologia , Polissacarídeos/farmacologia , Robinia/química , Vacinas de Produtos Inativados/imunologia , Vacinas de Produtos Inativados/farmacologia , Adjuvantes Imunológicos/administração & dosagem , Adjuvantes Imunológicos/uso terapêutico , Animais , Anticorpos Antivirais/sangue , Infecções por Caliciviridae/imunologia , Citocinas/metabolismo , Modelos Animais de Doenças , Combinação de Medicamentos , Vírus da Doença Hemorrágica de Coelhos/patogenicidade , Imunização , Interleucina-2/análise , Linfócitos , Medicina Tradicional Chinesa , Polissacarídeos/isolamento & purificação , Polissacarídeos/uso terapêutico , Própole/farmacologia , Coelhos , Taxa de Sobrevida , Vacinação , Vacinas de Produtos Inativados/administração & dosagem , Vacinas de Produtos Inativados/uso terapêutico , Vacinas Virais/imunologia , Vacinas Virais/farmacologia , Vacinas Virais/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA